4//SEC Filing
Menzel Garry E 4
Accession 0001415889-25-015700
CIK 0001623526other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 8:35 PM ET
Size
5.6 KB
Accession
0001415889-25-015700
Insider Transaction Report
Form 4
Menzel Garry E
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-06-03+29,747→ 29,747 totalExercise: $10.90Exp: 2035-06-02→ Common Stock (29,747 underlying)
Footnotes (1)
- [F1]The option shall vest in full on the earlier of: (i) June 3, 2026 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001556064
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 8:35 PM ET
- Size
- 5.6 KB